Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 23;14(3):241.
doi: 10.3390/jpm14030241.

Thymus Surgery Prospectives and Perspectives in Myasthenia Gravis

Affiliations
Review

Thymus Surgery Prospectives and Perspectives in Myasthenia Gravis

Paul Salahoru et al. J Pers Med. .

Abstract

The thymus is a lymphoid organ involved in the differentiation of T cells, and has a central role in the physiopathogenesis of Myasthenia Gravis (MG). This connection is proved by a series of changes in the level of neuromuscular junctions, which leads to a decrease in the amplitude of the action potential in the post-synaptic membrane. Because of this, the presence of anti-cholinergic receptor antibodies (AChR), characteristic of MG, is found, which causes the progressive regression of the effect of acetylcholine at the level of neuromuscular junctions, with the appearance of muscle weakness. The thymectomy is a surgical variant of drug therapy administered to patients with MG. In the case of patients with nonthymomatous MG, thymectomy has become a therapeutic standard, despite the fact that there is no solid scientific evidence to explain its positive effect. Videothoracoscopic surgery or robotic surgery led to a decrease in the length of hospital stay for these patients. This paper aims to synthesize the information presented in the literature in order to create a background for the perspectives of thymectomy.

Keywords: acetylcholine; myasthenia gravis; thoracic surgery; thymectomy; video-thoracoscopy (VATS).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Nitta T., Takayanagi H. Non-Epithelial Thymic Stromal Cells: Unsung Heroes in Thymus Organogenesis and T Cell Development. Front. Immunol. 2021;11:620894. doi: 10.3389/fimmu.2020.620894. - DOI - PMC - PubMed
    1. Klein L., Kyewski B., Allen P.M., Hogquist K.A. Positive and Negative Selection of the T Cell Repertoire: What Thymocytes See (and Don’t See) Nat. Rev. Immunol. 2014;14:377–391. doi: 10.1038/nri3667. - DOI - PMC - PubMed
    1. García Estévez D.A., Pardo Fernández J. Myasthenia gravis. Update on diagnosis and therapy. Miastenia gravis. Actualización diagnóstica y terapéutica. Med. Clin. 2023;161:119–127. doi: 10.1016/j.medcli.2023.04.006. - DOI - PubMed
    1. Martínez Torre S., Gómez Molinero I., Martínez Girón R. Puesta al día en la miastenia gravis [An update on myasthenia gravis] SEMERGEN. 2018;44:351–354. doi: 10.1016/j.semerg.2018.01.003. - DOI - PubMed
    1. Koneczny I., Cossins J., Waters P., Beeson D., Vincent A. MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters. PLoS ONE. 2013;8:e80695. doi: 10.1371/journal.pone.0080695. - DOI - PMC - PubMed

LinkOut - more resources